Universal antiviral approach could reshape Thailand's fight against persistent viruses
A new class of antiviral compounds aims to empower the body’s own defenses to fight a broad range of viruses. By amplifying the integrated stress response inside cells, these treatments could slow viral replication and move the world closer to a universal antiviral therapy. An international team reports promising findings that could help reduce the burden on Thailand’s health system.
Thailand’s public health landscape could benefit as human trials progress. HIV remains a major challenge, while Zika and herpes infections continue to pose concerns. RSV is a leading cause of serious respiratory illness in infants and older adults. Most current antivirals target specific viruses, and several infections still lack curative options. A universal antiviral would streamline treatment, cut costs, and improve patient outcomes across the country.
